Skip to content
MedGadget – Medical Technology and Healthcare News Website Logo

MedGadget

Where Medicine Meets Technology

  • Author
  • Contact Us
  • About Us
Top Stories
Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines
Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines
Bristol Myers Squibb Q3 2026 results graphic about pipeline data
Posted inPharmaceutical

Bristol Myers Squibb Q3 2026 Results: What the Pipeline Data on CELMoDs and Admilparant Show

The Bristol Myers Squibb Q3 2026 results include CELMoD, admilparant and RYZ101 updates. What each result shows and what is pending.
Continue Reading
October 30, 2026
Laurus Labs Galenvs acquisition graphic about oligonucleotide technology
Posted inBio Technology

Laurus Labs Galenvs Acquisition: The Oligonucleotide and Nanoparticle Technology Behind the Deal

The Laurus Labs Galenvs acquisition buys oligonucleotide and nanoparticle skills. What the technology involves and what is not shown.
Continue Reading
October 30, 2026
Fortis Healthcare acquisition graphic about care quality in Bengaluru
Posted inHealthcare Services

Fortis Healthcare Acquisition of Suguna Hospital: What Consolidation Means for Care Quality in Bengaluru

The Fortis Healthcare acquisition adds 110 beds in north-west Bengaluru. What evidence says about hospital deals and quality.
Continue Reading
October 30, 2026
Top Categories
Healthcare IT
Healthcare IT
Medical Device
Medical Device
Pharmaceutical
Pharmaceutical
Graphic: BNT113 clinical trial, progression-free survival endpoint missed and overall survival pending in HPV16-positive head and neck cancer
Posted inPharmaceutical

BNT113 Clinical Trial Disappoints, but Survival Data Await

The BNT113 clinical trial missed its progression-free survival goal in HPV16-positive head and neck cancer. Overall survival analysis continues.
October 15, 2026
Graphic: India pharma market growth, two overlapping datasets showing 17.1% and 13.5% for September 2026
Posted inPharmaceutical

India Pharma Market Growth Surges, but Datasets Disagree

India pharma market growth hit 17.1% in September per IQVIA-based research but about 13.5% per Pharmarack. Why they differ and what both agree on.
October 15, 2026
Graphic: NIPER Raebareli as a training hub linked to 25 clinical trial sites in emerging geographies
Posted inLife Science

NIPER Raebareli Training Hub Gives Trials a Promising Boost

NIPER Raebareli will host a clinical research training and certification centre under an MoU with AstraZeneca India. What it covers and what is undisclosed.
October 15, 2026
Graphic: Indian medical device regulation network linking regulator, hospitals and batch tracing for coronary stents
Posted inMedical Device

Indian Medical Device Regulation Faces Tough Stent Test

Indian medical device regulation faces a test as the Health Ministry is asked to examine stent safety. How oversight works and what reforms are floated.
October 15, 2026
Graphic: Biocon Genentech settlement sets Pebrilzo pertuzumab biosimilar launch dates for EU, UK and US
Posted inPharmaceutical

Biocon Genentech Settlement Sets Bold Pebrilzo Timeline

The Biocon Genentech settlement sets Pebrilzo launch dates: EU/UK Q1 2027, US Q3 2028, subject to approvals. What is confirmed and what is not.
October 15, 2026
Graphic: Par Health drug recall of argatroban injection, an alert symbol with 22 lots and particulate matter
Posted inPharmaceutical

Par Health Drug Recall: What the Argatroban Particle Notice Means for Hospitals

Par Health drug recall: 22 lots of argatroban injection pulled over particles. What the drug does, what hospitals must do and what the notice leaves open.
October 15, 2026
Graphic: oral GLP-1/GIP treatment VK2735 enters Phase 3, a rising curve showing 13 weeks of tablet data with 68 weeks still to test
Posted inPharmaceutical

Viking Starts Phase 3 of an Oral GLP-1/GIP Treatment: What Is Proven and What Is Not

Oral GLP-1/GIP treatment VK2735 enters Phase 3 in the SUNRISE studies. What 13 weeks of tablet data show, what is unproven and what to watch next.
October 15, 2026
Timeline graphic: Alaunos Velaris Therapeutics acquisition, from deal close in 2026 through first trial filings in 2027, proof-of-concept data in 2028 and funded runway into 2029
Posted inBio Technology

Alaunos Acquires Velaris Therapeutics and Announces $350 Million Financing for Pulmonary Hypertension Research

Alaunos Velaris Therapeutics acquisition closes with a $350M Fairmount-led financing for pulmonary hypertension drugs. None has been tested in people.
October 14, 2026
Graphic: Suki $90 million funding, a flow from listening to documenting to acting with AI agents beside figures of 450-plus organisations and 30-plus tech partners
Posted inHealthcare IT

Healthcare AI Startup Suki Raises $90 Million to Expand Clinical AI Agents and Hospital Automation

Suki $90 million funding: a Series E to build AI agents for referrals, prior authorisations and scheduling. Valuation was not disclosed.
October 14, 2026
Graphic: Johns Hopkins OpenEvidence AI partnership, two overlapping circles labelled clinical care and medical education beside the 13 October 2026 announcement date
Posted inHealthcare IT

Johns Hopkins Medicine Partners With OpenEvidence on AI Clinical Care and Medical Education

Johns Hopkins OpenEvidence AI partnership will shape clinical tools and medical training. No timeline, scope or financial terms were disclosed.
October 14, 2026

Posts pagination

Previous page 1 … 7 8 9 10 11 … 25 Next page

All Categories

  • Bio Technology
  • Healthcare IT
  • Healthcare Services
  • Life Science
  • Medical Device
  • Pharmaceutical
  • Press Releases
  • Uncategorized
Press Releases
Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines
Posted inPress Releases

Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines

Firefly Neuroscience and NeuroSigma Expand Access to Non-Drug Pediatric ADHD Treatment
Posted inPress Releases

Firefly Neuroscience and NeuroSigma Expand Access to Non-Drug Pediatric ADHD Treatment

InSilicoTrials Joins ARPA-H CIRCLE Program to Advance Digital Health Through Critical Care Digital Twins
Posted inPress Releases

InSilicoTrials Joins ARPA-H CIRCLE Program to Advance Digital Health Through Critical Care Digital Twins

Grünenthal and DKSH Expand Pain Medicine Partnership Across Eight Asia-Pacific Markets
Posted inPress Releases

Grünenthal and DKSH Expand Pain Medicine Partnership Across Eight Asia-Pacific Markets

Copyright 2026 — MedGadget.
Scroll to Top